Insider holders · CIK 0001347178
Vanda Pharmaceuticals Inc. · VNDA
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Mihael Hristos PolymeropoulosPresident and CEO | 1,178,970 | — | 1,178,970 | Mar 4, 2019 · 5:10 pm EST | Form 4 |
| Deerfield International Master Fund, L.P.10% Owner | — | 693,171 | 693,171 | Sep 26, 2016 · 5:29 pm EDT | Form 4 |
| Deerfield Special Situations Fund, L.P.10% Owner | — | 693,171 | 693,171 | Sep 26, 2016 · 5:29 pm EDT | Form 4 |
| James E Flynn10% Owner | — | 693,171 | 693,171 | Sep 26, 2016 · 5:29 pm EDT | Form 4 |
| DEERFIELD PARTNERS, L.P.10% Owner | — | 693,171 | 693,171 | Sep 26, 2016 · 5:29 pm EDT | Form 4 |
| Deerfield Mgmt L.P.10% Owner | — | 693,171 | 693,171 | Sep 26, 2016 · 5:29 pm EDT | Form 4 |
| DEERFIELD MANAGEMENT CO10% Owner | — | 693,171 | 693,171 | Sep 26, 2016 · 5:29 pm EDT | Form 4 |
| Richard W DuganDirector | 219,054 | — | 219,054 | Jun 8, 2026 · 4:20 pm EDT | Form 4 |
| James Patrick KellyEVP & Chief Financial Officer | 209,746 | — | 209,746 | Mar 4, 2019 · 5:06 pm EST | Form 4 |
| Gian Piero ReverberiSVP & Chief Commercial Officer | 167,989 | — | 167,989 | Mar 4, 2019 · 5:12 pm EST | Form 4 |
| Phaedra ChrousosDirector | 164,950 | — | 164,950 | Jun 8, 2026 · 4:23 pm EDT | Form 4 |
| Anne Sempowski WardDirector | 160,667 | — | 160,667 | Jun 8, 2026 · 4:19 pm EDT | Form 4 |
| Gunther BirznieksSVP, Business Development | 151,251 | — | 151,251 | Mar 4, 2019 · 5:02 pm EST | Form 4 |
| Tage HonoreDirector | 135,069 | — | 135,069 | Jun 8, 2026 · 4:17 pm EDT | Form 4 |
| Richard L. GulinoSVP, General Counsel & Sec. | 115,073 | — | 115,073 | Mar 2, 2018 · 5:33 pm EST | Form 4 |
| Stephen Ray MitchellDirector | 112,846 | — | 112,846 | Jun 8, 2026 · 4:15 pm EDT | Form 4 |
| Daniel Patrick McGuireSVP, GC and Secretary | 109,982 | — | 109,982 | Jun 8, 2026 · 4:39 pm EDT | Form 4 |
| Charles Cliff DuncanDirector | 98,701 | — | 98,701 | Jun 8, 2026 · 4:21 pm EDT | Form 4 |
| Timothy WilliamsSVP & General Counsel | 60,000 | — | 60,000 | Mar 1, 2019 · 4:27 pm EST | Form 4 |
| Paolo BaroldiSVP & Chief Medical Officer | 54,365 | — | 54,365 | Jan 5, 2017 · 5:13 pm EST | Form 4 |
| Thomas WatkinsDirector | 25,000 | — | 25,000 | Jun 15, 2018 · 4:30 pm EDT | Form 4 |
| Michael F ColaDirector | 10,000 | — | 10,000 | Jun 15, 2018 · 4:32 pm EDT | Form 4 |
| Vincent MilanoDirector | 10,000 | — | 10,000 | Jun 15, 2018 · 4:30 pm EDT | Form 4 |
| Kenneth BateDirector | 5,000 | — | 5,000 | Jun 19, 2017 · 9:58 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.